Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Shrinking team NBB
FTE fell two years in a row, from 53.7 to 46.1.
-
Busy address KBO
26 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Inbiose from Gent, company number BE0534887593, closed financial year 2025 with a result of € -1.6 million after tax. For that financial year Inbiose recorded revenue of € 6.3 million and equity of € 3.6 million. Compared with financial year 2024, the result moved from € -3.8 million to € -1.6 million. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 3.6 million
▲ € 10.6 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.6 million
▲ 58 % less loss than in 2024
Profit after tax over the fiscal year.
€ 1.6 million
▲ 109% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.5 million.
People and assets in 2025
46.1
▼ 5.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 4.8 million
▲ 7% vs 2024
€ 103,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 6,471
▼ 54% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 11 million
▼ 39% vs 2024
Loans from banks and other lenders, long and short.
€ 959,620
▲ 15% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 85 days on average.
€ 1.4 million
▲ 212% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | € 1,256,692 | € 2,043,966 | € 6,319,893 | ▲ 209% |
| Gross margin | € 2,228,727 | - | - | - | |
| Profit after taxes | € -6,520,752 | € -3,318,503 | € -3,791,505 | € -1,591,580 | ▲ € 2.2 million |
| Equity | € -6,198,837 | € -3,135,052 | € -6,926,557 | € 3,638,445 | ▲ € 10.6 million |
| Total debts | € 13,357,342 | € 14,069,045 | € 20,465,340 | € 13,533,283 | ▼ 34% |
| Cash | € 1,060,243 | € 617,066 | € 784,666 | € 1,639,332 | ▲ 109% |
| Retained profit | € -18,693,837 | € -22,012,340 | € -25,803,845 | € -1,499,815 | ▲ € 24.3 million |
| Bank debt | € 11,992,228 | € 11,766,738 | € 18,126,310 | € 10,967,138 | ▼ 39% |
| Balance sheet total | € 7,158,505 | € 10,933,993 | € 13,538,783 | € 17,181,531 | ▲ 27% |
| Employees (FTE) | 53.5 | 53.7 | 51.3 | 46.1 | ▼ 5.2 |
Key figures of Inbiose, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Inbiose?
What happened at Inbiose in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jakub Kalinowksi stepped down as director. NBB
- Pelin Yilmaz stepped down as director. NBB
- Joeri Beauprez stepped down as director. NBB
- Marcus Florent Oscar Zabeau stepped down as director. NBB
- Jean Prevot stepped down as director. NBB
- Soetaert BV stepped down as director. NBB
- Federale Participatie- en Investeringsmaatschappij - afgekort SFPIM stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.6 million. Source: NBB ↗
In short
From € 6.5 million loss in 2022 to € 1.6 million loss in 2025.
On average € 41,700 of value added per employee in 2022.
Pays suppliers within 85 days on average.
A new publication or filing at Inbiose? We notify you, reason included.
Follow InbioseDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT, QBIC Feeder Fund, QBIC Arkiv Fund comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
InbioseThe shares are held by SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT (37.5%), QBIC Feeder Fund (9.3%) and QBIC Arkiv Fund (9.3%). It owns 50% of Benebiose itself.
Directors
According to the 2025 annual accounts
Jakub Kalinowksi
Director
since 2026 · until 2032
since 2025 · until 2031
Pelin Yilmaz
Director
since 2026 · until 2032
since 2025 · until 2031
Jean Prevot
Director
since 2025 · until 2031
since 2025 · until 2031
Federale Participatie- en Investeringsmaatschappij - afgekort SFPIM
Director · represented by Goedele Ertveldt
Also active at: Aviapartner Belgium, Société Anonyme Belge de Constructions Aéronautiques, Société Nationale de Construction Aérospatiale, COMETSAMBRE, ASCO INDUSTRIES, ZEPHYR - FIN, Sabena Aerospace Engineering, reMYND +57 more
since 2025 · until 2031
Clemence Delcourt
Director
since 2025 · until 2026
Director · represented by Barbara Freitag
since 2025 · until 2025
Dirk Abeel Consulting BV
Director · represented by Dirk Abeel
since 2026 · until 2026
Shareholders
Participations
50%
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 82 box 41
9052 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 26 companies are registered at this address.
All companies at this address →CONTREL EUROPE
€ 250,724 gross margin · 2025
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT
€ 1.4 million gross margin · 2025
VP VENTURES
€ -1,670 gross margin · 2025
SENSNET
APCOR R&M
€ -12,717 gross margin · 2024
+21 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0534.887.593
- VAT number
- BE 0534.887.593
- Registered office
- Technologiepark-Zwijnaarde 82 bus 41, 9052 Gent
- Names & denominations
- Inbiose
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 31 May 2013
- Peppol
- Active · Active since 4 Nov 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van andere chemische producten, neg
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige zakelijke dienstverlening, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten